Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam with esketamine for pediatric MRI sedation
ChiCTR2400090337Phase 4Not yet recruiting
- Sponsor
- Xi'an International Medical Center Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of midazolam and esketamine (4 arms), sponsored by Xi'an International Medical Center Hospital. Primary endpoint: Success rate of magnetic resonance examination. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
midazolamesketamine
Beyond the preview
Go deeper on ChiCTR2400090337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090337.